143 related articles for article (PubMed ID: 2439343)
1. CDDP and 5-FU after prior VBM or VBM after prior CDDP and 5-FU in the management of recurrent squamous cell carcinoma of the head and neck?
Grimaldi A; Merlano M; Gardin G; Rosso R
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1539-40. PubMed ID: 2439343
[No Abstract] [Full Text] [Related]
2. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
Clavel M; Vermorken JB; Cognetti F; Cappelaere P; de Mulder PH; Schornagel JH; Tueni EA; Verweij J; Wildiers J; Clerico M
Ann Oncol; 1994 Jul; 5(6):521-6. PubMed ID: 7522527
[TBL] [Abstract][Full Text] [Related]
3. Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.
Smith RE; Heilbrun LK; Bottomley RM; Gad-el-Mawla N; Fletcher W
Cancer; 1986 Dec; 58(11):2382-5. PubMed ID: 2429754
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
Iop A; Cartei G; Isaia A
Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
Tellez-Bernal E; Belehradek M; Recondo G; Cvitkovic E; Leridant AM; Vericel R; Armand JP
Am J Clin Oncol; 1990 Oct; 13(5):452-4. PubMed ID: 1699403
[TBL] [Abstract][Full Text] [Related]
7. Alternating regimens in recurrent and metastatic squamous cell carcinoma of the head and neck.
Cognetti F; Molinari A; Carlini P; Frassineti GL; Pinnarò P; Marangolo M
Oncology; 1987; 44(5):270-2. PubMed ID: 2444912
[TBL] [Abstract][Full Text] [Related]
8. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
9. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.
Amrein PC; Weitzman SA
J Clin Oncol; 1985 Dec; 3(12):1632-9. PubMed ID: 2415693
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
Browman GP; Archibald SD; Young JE; Hryniuk WM; Russell R; Kiehl K; Levine MN
J Clin Oncol; 1983 Dec; 1(12):787-92. PubMed ID: 6366132
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck.
Mercier RJ; Neal GD; Mattox DE; Gates GA; Pomeroy TC; Von Hoff DD
Cancer; 1987 Dec; 60(11):2609-12. PubMed ID: 3676999
[TBL] [Abstract][Full Text] [Related]
14. 96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemia.
Recondo G; Benhamed M; Cvitkovic E; Marandas P; Armand JP
Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1529-33. PubMed ID: 2480245
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
[TBL] [Abstract][Full Text] [Related]
16. Non-platinum-containing combination chemotherapy for stage III-IV head and neck squamous carcinoma.
Veronesi A; Magri MD; Tirelli U; Galligioni E; Frustaci S; Crivellari D; Tumolo S; Grigoletto E
Tumori; 1983 Aug; 69(4):323-6. PubMed ID: 6194600
[TBL] [Abstract][Full Text] [Related]
17. [Factors modifying remission in cytostatic chemotherapy of squamous cell carcinoma recurrence in the area of the head and neck].
Scherlacher A; Jakse R; Lehnert M; Haas J
Laryngorhinootologie; 1989 Aug; 68(8):425-32. PubMed ID: 2476996
[TBL] [Abstract][Full Text] [Related]
18. Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.
Vogl SE; Komisar A; Kaplan BH; Engstrom PF; Kasule OH; Stolbach L; Lerner H; Muggia F
Cancer; 1986 Feb; 57(4):706-10. PubMed ID: 2417680
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
[TBL] [Abstract][Full Text] [Related]
20. Induction therapy in head and neck cancer. A comparison of two regimens.
Spaulding M; Ziegler P; Sundquist N; Klotch D; Lee K; Khan A; Lore J
Cancer; 1986 Mar; 57(6):1110-4. PubMed ID: 2417692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
